Plenary on Healthcare - A world leader and innovator: creating a strong innovation ecosystem for life science in Europe
On Tuesday, 20 October, AmCham EU hosted a plenary meeting on healthcare. The discussion focused on the strengths and weaknesses of the EU innovation ecosystem in contrast with US approaches, the implications of the pharma strategy and the role of programmes such as Horizon Europe and EU4Health to entice European health innovation.
Participants included Cristian-Silviu Busoi, Member of the European Parliament (EPP, RO) and Robert Grant, Director of International Policy, U.S. Chamber of Commerce Global Innovation Policy Center (GIPC).
The official AmCham EU Chair handover also took place during the plenary meeting. Once again, we would like to thank outgoing Chairman Maxime Bureau (3M) and welcome the new AmCham EU Chair, Zeger Vercouteren (J&J).
Related items
:focal())
Healthcare, competitiveness, innovation and simplification
Europe’s life sciences sector sits at the heart of the EU’s competitiveness agenda. It supports advanced manufacturing and helps bring new treatments and technologies to patients. Yet companies deciding where to invest need a regulatory environment that is predictable and open to global cooperation.
The European Commission’s work on the Biotech Act and the targeted revision of the Medical Devices and In Vitro Diagnostics Regulations (MDR/IVDR) offers an opportunity to improve that environment. Both files can help make Europe a stronger location for life sciences investment.
The EU should use this moment to build a framework that keeps pace with scientific progress. That means faster and clearer procedures. It also means better use of data and intellectual property rules that recognise the realities of global supply chains.
:focal())
Strengthening EU competitiveness through an adaptive MDR/IVDR framework
A global approach to strengthening Europe’s biotechnology ecosystem
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.